We predict that the PR55α B subunit of PP2A plays a dominant role in modulating PP2A activity in malignant melanoma and potentially in other cancers with dysfunctional or null PTEN, promoting an oncogenic role of PP2A as opposed to its classical tumor suppressor function. Here, PTPA is linked to cancer.